These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10778879)

  • 1. Tissue-specific actions of antidiabetic thiazolidinediones on the reduced fatty acid oxidation in skeletal muscle and liver of Zucker diabetic fatty rats.
    Ide T; Nakazawa T; Mochizuki T; Murakami K
    Metabolism; 2000 Apr; 49(4):521-5. PubMed ID: 10778879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of troglitazone on substrate storage and utilization in insulin-resistant rats.
    Sreenan S; Keck S; Fuller T; Cockburn B; Burant CF
    Am J Physiol; 1999 Jun; 276(6):E1119-29. PubMed ID: 10362626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes.
    Shimabukuro M; Zhou YT; Levi M; Unger RH
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2498-502. PubMed ID: 9482914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
    Murakami K; Tobe K; Ide T; Mochizuki T; Ohashi M; Akanuma Y; Yazaki Y; Kadowaki T
    Diabetes; 1998 Dec; 47(12):1841-7. PubMed ID: 9836514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UCP3 gene expression does not correlate with muscle oxidation rates in troglitazone-treated Zucker fatty rats.
    Oberkofler H; Neschen S; Esterbauer H; Waldhäusl W; Patsch W; Fürnsinn C
    Biochim Biophys Acta; 2000 Dec; 1517(1):113-8. PubMed ID: 11118623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of conjugated linoleic acid and troglitazone on lipid accumulation and composition in lean and Zucker diabetic fatty (fa/fa) rats.
    Wendel AA; Belury MA
    Lipids; 2006 Mar; 41(3):241-7. PubMed ID: 16711598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats.
    Shimabukuro M; Zhou YT; Lee Y; Unger RH
    J Biol Chem; 1998 Feb; 273(6):3547-50. PubMed ID: 9452481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
    Shibata T; Matsui K; Nagao K; Shinkai H; Yonemori F; Wakitani K
    Eur J Pharmacol; 1999 Jan; 364(2-3):211-9. PubMed ID: 9932726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats.
    Fulgencio JP; Kohl C; Girard J; Pégorier JP
    Diabetes; 1996 Nov; 45(11):1556-62. PubMed ID: 8866561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fructose and troglitazone on phospholipid fatty acid composition in rat skeletal muscle.
    Clore JN; Li L; Rizzo WB
    Lipids; 2000 Nov; 35(11):1281-7. PubMed ID: 11132187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats.
    Bonen A; Holloway GP; Tandon NN; Han XX; McFarlan J; Glatz JF; Luiken JJ
    Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R1202-12. PubMed ID: 19675275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of type-2 diabetes and troglitazone on the expression patterns of small intestinal sugar transporters and PPAR-gamma in the Zucker diabetic fatty rat.
    Corpe C; Sreenan S; Burant C
    Digestion; 2001; 63(2):116-23. PubMed ID: 11244250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.
    Wilmsen HM; Ciaraldi TP; Carter L; Reehman N; Mudaliar SR; Henry RR
    Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E354-62. PubMed ID: 12700163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.
    Furuta M; Yano Y; Gabazza EC; Araki-Sasaki R; Tanaka T; Katsuki A; Hori Y; Nakatani K; Sumida Y; Adachi Y
    Diabetes Res Clin Pract; 2002 Jun; 56(3):159-71. PubMed ID: 11947963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of uncoupling protein-2 mRNA by troglitazone in the pancreatic islets of Zucker diabetic fatty rats.
    Shimabukuro M; Zhou YT; Lee Y; Unger RH
    Biochem Biophys Res Commun; 1997 Aug; 237(2):359-61. PubMed ID: 9268716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troglitazone action is independent of adipose tissue.
    Burant CF; Sreenan S; Hirano K; Tai TA; Lohmiller J; Lukens J; Davidson NO; Ross S; Graves RA
    J Clin Invest; 1997 Dec; 100(11):2900-8. PubMed ID: 9389757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of troglitazone on plasma homocysteine, hepatic and red blood cell S-adenosyl methionine, and S-adenosyl homocysteine and enzymes in homocysteine metabolism in Zucker rats.
    Fonseca V; Keebler M; Dicker-Brown A; Desouza C; Poirier LA; Murthy SN; McNamara DB
    Metabolism; 2002 Jun; 51(6):783-6. PubMed ID: 12037736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
    Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troglitazone improves insulin-stimulated glucose utilization associated with an increased muscle glycogen content in obese Zucker rats.
    Oshida Y; Kako M; Nakai N; Shimomura Y; Li L; Sato J; Ohsawa I; Sato Y
    Endocr J; 1999 Oct; 46(5):723-30. PubMed ID: 10670760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.